Martin v. Secretary of Health and Human Services

United States Court of Federal Claims·Decided December 21, 2017·No. 16-318·Unpublished

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS

******************** * No. 16-318V JESSICA R. MARTIN, * Special Master Christian J. Moran On behalf of KM, * Filed: October 23, 2017 * Petitioner, * v. * Stipulation; diphtheria-tetanus- * acellular pertussis (DTaP); SECRETARY OF HEALTH AND * inactivated poliovirus (IPV); HUMAN SERVICES, * Haemophilus influenza type B * (Hib); pneumococcal conjugate Respondent. * (PCV); rotavirus; transverse * myelitis. ******************** *

Dan W. Bolton, III, Bolton Law, PLLC, Cary, NC, for Petitioner; Voris E. Johnson, Jr., United States Dep’t of Justice, Washington, DC, for Respondent.

UNPUBLISHED DECISION1

On October 20, 2017, the parties filed a joint stipulation concerning the petition for compensation filed by Jessica R. Martin, on behalf of KM, on March 11, 2016. In her petition, petitioner alleged that the diphtheria-tetanus-acellular pertussis (DTaP), inactivated poliovirus (IPV), Haemophilus influenza type B (Hib), pneumococcal conjugate (PCV) and rotavirus vaccines, which are contained in the Vaccine Injury Table, 42 C.F.R. §100.3(a), and which KM received on August 23, 2013, caused KM to suffer transverse myelitis (“TM”). Petitioner further alleges that KM suffered the residual effects of this injury for more than six months. Petitioner represents that there has been no prior award or settlement of a civil action for damages on KM’s behalf as a result of KM’s condition.

1 The E-Government Act, 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services), requires that the Court post this decision on its website. Pursuant to Vaccine Rule 18(b), the parties have 14 days to file a motion proposing redaction of medical information or other information described in 42 U.S.C. § 300aa-12(d)(4). Any redactions ordered by the special master will appear in the document posted on the website. Respondent denies that the influenza vaccine caused KM to suffer TM or any other injury. Nevertheless, the parties agree to the joint stipulation, attached hereto. The undersigned finds said stipulation reasonable and adopts it as the decision of the Court in awarding damages, on the terms set forth therein.

Damages awarded in that stipulation include:

1. A lump sum payment of $250,000.00 in the form of a check payable to petitioner as court-appointed guardian/conservator of the estate of KM. However, no payments shall be made until petitioner provides respondent with documentation establishing that she has been appointed as guardian/conservator of KM’s estate;

2. A lump sum of $9,500.00, which amount represents compensation of past unreimbursable expenses, in the form of a check payable to petitioner, Jessica R. Martin; and,

3. An amount sufficient to purchase the annuity contract described in paragraph 10 of the attached stipulation agreement, paid to the life insurance company from which the annuity will be purchased.

These amounts represent compensation for all damages that would be available under 42 U.S.C. § 300aa-15(a).

In the absence of a motion for review filed pursuant to RCFC, Appendix B, the clerk is directed to enter judgment in case 16-318V according to this decision and the attached stipulation.2

IT IS SO ORDERED.

S/Christian J. Moran Christian J. Moran Special Master

2 Pursuant to Vaccine Rule 11(a), the parties can expedite entry of judgment by each party filing a notice renouncing the right to seek review by a United States Court of Federal Claims judge. 2 IN THE UNITED STATES COURT OF FEDERAL CLAIMS

OFFICE OF SPECIAL MASTERS

JESSICA R. MARTIN, ) On behalf of KM, ) ) Petitioner, ) v. ) No. 16-318V ) Special Master Moran SECRETARY OF HEALTH AND HUMAN ) SERVICES, ) ) Respondent. ) )

STIPULATION

The parties hereby stipulate to the following matters:

1. Jessica R. Martin (“petitioner”), on behalf of her minor daughter, KM, filed a petition

for vaccine compensation under the National Vaccine Injury Compensation Program, 42 U.S.C.

§300aa-10 to 34 (the “Vaccine Program”). The petition seeks compensation for injuries

allegedly related to KM’s receipt of diphtheria-tetanus-acellular pertussis (DTaP), inactivated

poliovirus (IPV), Haemophilus influenza type B (Hib), pneumococcal conjugate (PCV) and

rotavirus vaccines, which vaccines are contained in the Vaccine Injury Table (the “Table”), 42

C.F.R. § 100.3 (a).

2. KM received the DTaP, IPV, Hib, PCV and rotavirus immunizations on August 23,

2013.

3. The vaccines were administered within the United States.

4. Petitioner alleges that KM suffered from transverse myelitis (“TM”) as a result of

receiving the above-referenced vaccines. Petitioner further alleges that KM has suffered the

residual effects of her TM for more than six months. 5. Petitioner represents that there has been no prior award or settlement of a civil action

for damages on behalf of KM as a result of her condition.

6. Respondent denies that the vaccines caused KM to suffer from TM, or any other

injury or her current condition.

7. Maintaining their above-stated positions, the parties nevertheless now agree that the

issues between them shall be settled and that a decision should be entered awarding the

compensation described in paragraph 8 of this Stipulation.

8. As soon as practicable after an entry of judgment reflecting a decision consistent with

the terms of this Stipulation, and after petitioner has filed an election to receive compensation

pursuant to 42 U.S.C. § 300aa-21(a)(1), the Secretary of Health and Human Services will issue

the following vaccine compensation payments:

a. A lump sum of $250,000.00, in the form of a check payable to petitioner as court- appointed guardian/conservator of the estate of KM, for the benefit of KM. No payments shall be made until petitioner provides respondent with documentation establishing that she has been appointed as guardian/conservator of KM’s estate;

b. A lump sum of $9,500.00, which amount represents compensation for past unreimbursable expenses, in the form of a check payable to petitioner, Jessica R. Martin; and,

c. An amount sufficient to purchase the annuity contract described in paragraph 10 below, paid to the life insurance company from which the annuity will be purchased (the “Life Insurance Company”).

These amounts represent compensation for all damages that would be available under 42

U.S.C. § 300aa-15(a).

9. The Life Insurance Company must have a minimum of $250,000,000.00 capital and

surplus, exclusive of any mandatory security valuation reserve. The Life Insurance Company

must have one of the following ratings from two of the following rating organizations:

a. A.M. Best Company: A++, A+, A+g, A+p, A+r, or A+s;

2 b. Moody’s Investor Service Claims Paying Rating: Aa3, Aa2, Aa1, or Aaa;

c. Standard and Poor’s Corporation Insurer Claims-Paying Ability Rating: AA-, AA, AA+, or AAA;

d. Fitch Credit Rating Company, Insurance Company Claims Paying Ability Rating: AA-, AA, AA+, or AAA.

10. The Secretary of Health and Human Services agrees to purchase an annuity contract

Free access — add to your briefcase to read the full text and ask questions with AI

Martin v. Secretary of Health and Human Services, (uscfc 2017).

Martin v. Secretary of Health and Human Services (Martin v. Secretary of Health and Human Services) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

§ 300aa-10
42 U.S.C. § 300aa-10
§ 300aa-12
42 U.S.C. § 300aa-12(d)(4)
§ 300aa-15
42 U.S.C. § 300aa-15(a)
§ 300aa-21
42 U.S.C. § 300aa-21(a)(1)
Purposes
44 U.S.C. § 3501
§ 300a
42 U.S.C. § 300a